Home › Multiple Myeloma › Minnesota › Minneapolis
Pag-aaral pangklinika para sa Multiple Myeloma sa Minneapolis, MN
Isang pag-aaral para sa Multiple Myeloma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Minneapolis. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
Nagre-recruitPhase 2/3
- Minnesota Oncology - Minneapolis Clinic /ID# 278720, Minneapolis
AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
Nagre-recruitPhase 1/2
- Research Site, Minneapolis
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Nagre-recruitPhase 3
- University Of Minnesota Medical Center, Minneapolis
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Nagre-recruitPhase 3
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mi ang layo
Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
Nagre-recruitPhase 2
- Masonic Cancer Center at University of Minnesota, Minneapolis
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Nagre-recruitPhase 3
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Health Partners Inc, Minneapolis
- at 1 pa
Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma
Nagre-recruit
- University of Minnesota - Masonic Cancer Center, Minneapolis
Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma
Nagre-recruitPhase 2
- Minnesota Oncology Hematology, Minneapolis
IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers
Nagre-recruitPhase 1/2
- University of Minnesota, Minneapolis
Assessment of Allogeneic Hematopoietic Cell Transplantation in Medicare Beneficiaries With Multiple Myeloma
Nagre-recruitObservasyonal na pag-aaral
- Center for International Blood and Marrow Transplant Research, Minneapolis
Pag-aaral para sa Multiple Myeloma sa ibang lungsod
- New York City, NY59 pag-aaral
- Boston, MA45 pag-aaral
- Atlanta, GA42 pag-aaral
- Houston, TX39 pag-aaral
- Durham, NC36 pag-aaral
- Nashville, TN31 pag-aaral
- Denver, CO26 pag-aaral
- St. Louis, MO26 pag-aaral
- Rochester, MN25 pag-aaral
- Columbus, OH25 pag-aaral
- Chicago, IL24 pag-aaral
- Milwaukee, WI23 pag-aaral
Iba pang pag-aaral sa Minneapolis
- Non-Small Cell Lung Cancer29 pag-aaral
- Kanser sa Suso23 pag-aaral
- Kanser sa Ovary23 pag-aaral
- Kanser sa Prostate22 pag-aaral
- Pagkabigo ng Puso22 pag-aaral
- Kanser (lahat ng uri)21 pag-aaral
- Kanser ng Endometrium20 pag-aaral
- Colorectal Cancer20 pag-aaral
- Kanser sa Baga20 pag-aaral
- Acute Myeloid Leukemia19 pag-aaral
- Sakit ni Parkinson17 pag-aaral
- Sakit sa Coronary Artery15 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.